← All diseases
Brain and nervous system
Lewy body dementia
Do you want to receive a message when there is new research about Lewy body dementia? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, one sentence appears above each publication explaining what was studied — and you receive a message as soon as there is new research about Lewy body dementia. View what Premium costs.
Publications and studies (1347)
- A cell type enrichment analysis tool for brain DNA methylation data (CEAM). (2026/12/01) ♡
- Priorities to Improve Caregiving Experiences in Parkinson Disease: A Qualitative Study of Multiple Stakeholders. (2026/10/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Epileptiform discharges are associated with increased theta activity over time in patients with Lewy body dementia. (2026/09/11) ♡
- Progression to Dementia in Very Late-Onset Schizophrenia-Like Psychosis Stratified by Alzheimer's Disease and Lewy Body Disease Biomarkers: A Retrospective Cohort Study. (2026/09/01) ♡
- Cardiac Sympathetic Dysfunction Reveals Asymmetric Dopaminergic Neurodegeneration in Drug-naive Parkinson Disease. (2026/09/01) ♡
- Increased Binding of [(18)F]Nifene, a PET Imaging Probe for α4β2* Nicotinic Acetylcholinergic Receptors in Hippocampus-Subiculum of Postmortem Human Parkinson's Disease Brain. (2026/09/01) ♡
- Voice Disorders as Early Biomarkers of Cognitive Decline. (2026/08/11) ♡
- Stress, mood, and Parkinson's disease: selective dysregulation of corticotropin-releasing hormone and urocortin neurocircuits. (2026/08/10) ♡
- Activated microglial phenotypes in the hippocampal CA2 subfield are implicated in Lewy body disease progression. (2026/08/08) ♡
- Artificial intelligence-based 3D segmentation of tangle-associated TDP-43 in neurodegeneration. (2026/08/07) ♡
- Fine-scale individualized gyral folding-based cortical similarity networks reveal distinct organizational patterns in Alzheimer's disease and Lewy body dementia. (2026/08/06) ♡
- Timing and Duration of Prediabetic Metabolic Dysfunction Differentially Impact Cerebral Perfusion, Vascular Structure, and Behavior. (2026/08/05) ♡
- Data-driven trajectories of atrophy explain clinical heterogeneity across Lewy body diseases. (2026/08/05) ♡
- Vocal Fold Atrophy in Patients With Alzheimer's Disease and Related Dementias. (2026/08/03) ♡
- Impact of genetic variants in the longevity gene PPARGC1A and cerebrospinal fluid PPARγ levels on clinical trajectories in Parkinson's disease: Potential biomarkers for neurodegeneration and ageing. (2026/08/01) ♡
- Language and communication disorders in dementia with Lewy bodies versus Alzheimer's disease: Objective screening and subjective perspectives of patients, their caregivers and clinicians. (2026/08/01) ♡
- Shotgun metagenomic profiling of the gut microbiota in Parkinson's disease dementia and dementia with Lewy bodies. (2026/08/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Parkinson's disease genetics across diverse ancestries: an observational genetic study of causal and risk variants with translational implications. (2026/08/01) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Cognitive training and promoting a healthy lifestyle in isolated REM sleep behavior disorder: The randomized controlled trial CogTrAiL-RBD. (2026/08/01) ♡
- Decoding Prodromal Lewy Body Disease: Clinical Differences Between Isolated REM Sleep Behavior Disorder and Hyposmia With Dopamine Transporter Deficit. (2026/08/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The past, the present, and the future of preclinical mouse models for Alzheimer's disease and related dementias. (2026/08/01) ♡
- Longitudinal Systemic Transcriptomic Profiling and Neuropathological Deposition of Neutrophil Extracellular Traps in Parkinson's Disease. (2026/07/29) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Brain-Aggregated and Body-Aggregated Alpha-Synuclein in Lewy Body Disease: Sowing Initial Seeds of Understanding. (2026/07/28) ♡
- Alpha-Synuclein Seed Amplification Assay in CSF, Skin, and Submandibular Gland From Incidental Lewy Body Disease and Parkinson Disease. (2026/07/28) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Neuropathogenesis of Seizures in Patients With Alzheimer Disease and Lewy Body Dementia: Is There a Difference, and Does It Matter? (2026/07/28) ♡
- Neuropsychological Profile and Cognitive Trajectories of Patients With Biomarker Evidence of Alzheimer Disease or Dementia With Lewy bodies. (2026/07/28) ♡
- Neuropathologic Correlates of Seizures in Patients With Alzheimer Disease and Dementia With Lewy Bodies. (2026/07/28) ♡
- Greater Motor and Nonmotor Burden at Diagnosis Is Associated With Amyloid Copathology in Parkinson's Disease. (2026/07/28) ♡
- Comparative Screening of Alzheimer's Disease, Lewy Body Dementia, and Frontotemporal Dementia Using miRNA and Machine Learning. (2026/07/27) ♡
- Regulatory endorsement for the application of α-synuclein seed amplification assay as a susceptibility and risk biomarker for clinical trials targeting synucleinopathies. (2026/07/24) ♡
- Greater burden of Alzheimer's Co-pathology in women with Parkinson's disease dementia. (2026/07/24) ♡
- Using Wearable Devices to Monitor Activity and Sleep in Inpatients With Parkinson Disease With and Without Delirium: Feasibility and Acceptability Study. (2026/07/23) ♡
- E326K GBA polymorphism is associated with clinical and pathological features of synucleinopathy in the absence of overt Parkinson's disease or Lewy body dementia. (2026/07/22) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Cross-sectional analysis of variation in diagnosis of Lewy body dementia in three English regions: data from the DETERMIND programme. (2026/07/22) ♡
- Amygdalar nuclei vulnerability to protein aggregates in Lewy body diseases. (2026/07/21) ♡
- Spatial multi-omics identifies early synaptic pruning and context-specific dopaminergic vulnerability in synucleinopathies. (2026/07/21) ♡
- Plasma proteome profiling identified biomarkers for the differential diagnosis and molecular staging of neurodegenerative dementias. (2026/07/20) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Neuropathological correlates of imaging in dementia with Lewy bodies. (2026/07/17) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Cardiovascular risks in psychiatric disorders and psychiatric risks in cardiovascular disorders: implications for prevention and clinical management - a large-scale umbrella review encompassing 76 meta-analyses. (2026/07/17) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Brain-first and body-first subtypes of Lewy body disease. (2026/07/16) ♡
- Clinical heterogeneity of Pisa syndrome across Lewy body disorders: a multicenter comparison of Parkinson's disease and dementia with Lewy bodies. (2026/07/15) ♡
- Shotgun metagenomic analysis reveals taxonomic and functional alterations in the gut microbiome across prodromal and symptomatic Lewy body disease. (2026/07/15) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. The Prodromal Synucleinopathy Rating Scale: An Assessment in Patients With REM Sleep Behavior Disorder. (2026/07/14) ♡
- Peripheral and central inflammation associated with progressive cognitive decline in dementia with Lewy bodies. (2026/07/14) ♡
- Clinicopathologic Evaluation of Amyloid Clearance in Alzheimer Disease. (2026/07/12) ♡
- Thresholds for meaningful change in Mini-Mental State Examination scores in rare dementias. (2026/07/11) ♡
- Analytical and clinical validation of a novel proximity extension assay-based plasma biomarker panel in a cohort of prevalent neurodegenerative dementias. (2026/07/11) ♡
- Modeling Parkinson's pathology in human iPSC dopaminergic neurons uncovers key mechanisms of Lewy body formation and heterogeneity. (2026/07/10) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Defining and Measuring Cognitive Decline and Clinical Relevance. (2026/07/09) ♡
- REM sleep without atonia thresholds are associated with reduced cardiac MIBG uptake but not with DAT-SPECT binding in probable REM sleep behavior. (2026/07/09) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.